The GLP2 receptor (GLP2R) is a G protein-coupled receptor superfamily member closely related to the glucagon receptor (GLP1 receptor). Glucagon-like peptide-2 (GLP2) is a 33-amino acid proglucagon-derived peptide produced by intestinal enteroendocrine cells. Like glucagon-like peptide-1 (GLP1) and glucagon itself, it is derived from the proglucagon peptide encoded by the GCG gene. GLP2 stimulates intestinal growth and upregulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyteapoptosis. Moreover, GLP2 prevents intestinal hypoplasia resulting from total parenteral nutrition. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut and closely related to the glucagon receptor (GCGR) and the receptor for GLP1 (GLP1R).
^Brubaker PL, Drucker DJ (2002). “Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors”. Receptors & Channels. 8 (3–4): 179–88. doi:10.1080/10606820213687. PMID12529935.
Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, Drucker DJ (Sep 2000). “Enteroendocrine localization of GLP-2 receptor expression in humans and rodents”. Gastroenterology. 119 (3): 744–55. doi:10.1053/gast.2000.16489. PMID10982769.
Thulesen J, Knudsen LB, Hartmann B, Hastrup S, Kissow H, Jeppesen PB, Ørskov C, Holst JJ, Poulsen SS (Jan 2002). “The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist”. Regulatory Peptides. 103 (1): 9–15. doi:10.1016/S0167-0115(01)00316-0. PMID11738243.
Koehler JA, Yusta B, Drucker DJ (Feb 2005). “The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways”. Molecular Endocrinology (Baltimore, Md.). 19 (2): 459–73. doi:10.1210/me.2004-0196. PMID15471943.
Ørskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ (Jan 2005). “GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors”. Regulatory Peptides. 124 (1–3): 105–12. doi:10.1016/j.regpep.2004.07.009. PMID15544847.
Mahon MJ, Shimada M (Jan 2005). “Calmodulin interacts with the cytoplasmic tails of the parathyroid hormone 1 receptor and a sub-set of class b G-protein coupled receptors”. FEBS Letters. 579 (3): 803–7. doi:10.1016/j.febslet.2004.12.056. PMID15670850.
Estall JL, Koehler JA, Yusta B, Drucker DJ (Jun 2005). “The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation”. The Journal of Biological Chemistry. 280 (23): 22124–34. doi:10.1074/jbc.M500078200. PMID15817468.
Sams A, Hastrup S, Andersen M, Thim L (Feb 2006). “Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines”. European Journal of Pharmacology. 532 (1–2): 18–23. doi:10.1016/j.ejphar.2005.12.001. PMID16448646.